Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-25T08:52:46.971Z Has data issue: false hasContentIssue false

We should allow family presence for hospitalized patients in isolation for coronavirus disease 2019 (COVID-19)

Published online by Cambridge University Press:  04 April 2022

Jorge L. Salinas*
Affiliation:
Division of Infectious Diseases & Geographic Medicine, Stanford University, Stanford, California
*
Author for correspondence: Jorge L. Salinas MD, E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

To the Editor—In our field, we rapidly implement preventative measures during outbreaks or epidemics. However, we may keep such measures longer than needed once the epidemiologic situation has changed. Among the many reasons for differential speeds in implementation and de-implementation of preventative measures, one can cite fatigue, lack of evidence, competing priorities, and even fear. Here, I postulate that one measure that may have been appropriate early on in the pandemic but needs to be revisited is allowing family presence for hospitalized patients in isolation for coronavirus disease 2019 (COVID-19).

Why were these restrictions implemented?

Visitors could become infected

Infection control professionals are charged with mitigating the risk of infection spread among healthcare personnel, patients, and visitors. Visitors could potentially become infected while in the room of a person isolated because of COVID-19. However, the risk of transmission of infection to visitors can be greatly mitigated. In many places visitors are required to be vaccinated, healthcare facilities have engineering controls (increased air exchanges), and personal protective equipment (PPE) is available. These measures have proven safe for healthcare workers throughout the pandemic. Furthermore, patients admitted because of COVID-19 are unlikely to be at the peak of infectiousness, and visitors may have already had COVID-19 as part of the same transmission chain and may be unlikely to be reinfected soon after recovery.

Visitors may be infected and transmit disease to other people present in the healthcare setting

Visitors may unknowingly carry an asymptomatic or presymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection. However, that is true for all visitors, regardless of the COVID-19 status of the visited patient. This is why universal infection controls are in place (eg, universal masking).

Implementation may be burdensome

Educating visitors on donning and doffing of PPE may add to the chores of already busy healthcare workers. However, we currently do this for visitors to patients on isolation for other reasons (eg, tuberculosis and C. difficile). This protocol is not unique to COVID-19. However, hospital administration may need to provide extra support for this added task.

Contribution to community spread

At this point in the pandemic, most country governments have started transitioning to a mitigation strategy in which some degree of transmission is considered acceptable. Potential transmission from patients to visitors is unlikely to meaningfully impact community transmission.

Limited PPE supply

The beginning of the pandemic was characterized by a problematic shortage of PPE and other supplies. Fortunately, the availability of PPE has increased tremendously in the United States. Discussions with supply chain departments will need to be undertaken to ensure that adequate stock is available.

Why should these restrictions go away?

Visitor restrictions adversely affect patients and their families well-being

Visitor restrictions may lead to incomplete grief and emotional distress by patients, families, and healthcare workers. They are a barrier to high-quality communication and decision making; they may perpetuate inequities; and they may be associated with poor clinical outcomes.Reference Hart and Taylor 1

Restricting family presence may lead to longer stays and delayed decisions to limit treatment prior to death

A recent study showed a ∼3 days longer hospital stay after implementation of policies preventing visitors and a hazard ratio of ∼2 for a longer time to care parameters including do not resuscitate, do not intubate, and comfort care. Reference Azad, Al-Kawaz, Turnbull and Rivera-Lara2 Given that engaging patients and families has been advocated for the prevention of healthcare-associated infections, it is not unreasonable to speculate that some of the increases in HAI reported nationwide Reference Weiner-Lastinger, Pattabiraman and Konnor3 may, in part, be associated with restrictive visitation policies.

The way forward

Safe family presence can be achieved. Several centers have successfully achieved safe policies to allow visitors to patients with COVID-19 in special circumstances, such as end of life, delivery and birth, and for pediatric patients. One remaining question is whether visitors need to be offered a fit tested N95.

Fit testing is an employment-based requirement to ensure that workers who are repeatedly exposed to airborne diseases do not develop occupational infections. The Centers for Disease Control and Prevention and other health departments have advocated for N95 respirators and KN95 mask use in the community without the need for fit testing. Reference Andrejko, Pry and Myers4 Requiring fit testing could become an operational barrier preventing family members at the bedside, and it is not clear that is strictly needed.

In summary, I believe it is time to expand visitation to all COVID-19 patients. The risk benefit ratio has shifted toward allowing visitors for all patients regardless of their COVID-19 status. Fortunately, most of the reasons visitor restriction policies implemented are no longer present, and allowing visitors for patients in isolation because of COVID-19 is beneficial for patients, family members, and the healthcare system as a whole.

Acknowledgments

Financial support

No financial support was provided relevant to this article.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

References

Hart, JL, Taylor, SP. Family presence for critically ill patients during a pandemic. Chest 2021;160:549557.CrossRefGoogle ScholarPubMed
Azad, TD, Al-Kawaz, MN, Turnbull, AE, Rivera-Lara, L. Coronavirus disease 2019 policy restricting family presence may have delayed end-of-life decisions for critically ill patients. Crit Care Med 2021;49:e1037–e9.CrossRefGoogle ScholarPubMed
Weiner-Lastinger, LM, Pattabiraman, V, Konnor, RY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2022;43:1225.CrossRefGoogle Scholar
Andrejko, KL, Pry, JM, Myers, JF, et al. Effectiveness of face mask or respirator use in indoor public settings for prevention of SARS-CoV-2 infection—California, February–December 2021. Morb Mortal Wkly Rep 2022;71:212216.CrossRefGoogle ScholarPubMed